Database : HANSEN
Search on : HANSENOSTATICOS/FARMACOL [Subject descriptor]
References found : 24 [refine]
Displaying: 1 .. 20   in format [Detailed]

page 1 de 2 go to page        

  1 / 24 HANSEN  
              next record last record
select
to print
Id:18385
Author:Consigny, Sophie; Bentoucha, Abdelhalim; Bonnafous, Pascale; Grosset, Jacques; Ji, Baohong
Title:Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice ..-
Source:s.l; s.n; 2000. 3 p. tab.
Abstract:Bactericidal activities of HMR 3647 (HMR), moxifloxacin (MXFX), and rifapentine (RPT) against Mycobacterium leprae, measured by the proportional bactericidal technique in the mouse footpad system, were compared with those of the established antileprosy drugs clarithromycin (CLARI), ofloxacin (OFLO), and rifampin (RMP. Administered in five daily doses of 100 mg/kg of body weight, HMR appeared slightly more bactericidal than CLARI. In a single dose, MXFX at 150 mg/kg was more active than the same dose of OFLO and displayed exactly the same level of activity as RMP at 10 mg/kg; the combination MXFX-minocycline (MINO) (MM) was more bactericidal than the combination OFLO-MINO (OM); RPT at 10mg/kg was more bactericidal than the same dose of RMP and even more active than the combination RMP-OFLO-MINO (ROM); the combination RPT-MXFX-MINO (PMM) killed 99.9% of viable M. leprae and was slighthy more bactericidal than RPT alone, indicating that the combination PMM showed an additive effect against M. leprae (AU).
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/admin
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/farmacocin
HANSENOSTATICOS/uso terap
MYCOBACTERIUM LEPRAE
TESTES DE SENSIBILIDADE MICROBIANA/métodos
DROGAS EM INVESTIGACAO/admin
DROGAS EM INVESTIGACAO/anal
DROGAS EM INVESTIGACAO/uso terap
BACTERICIDAS
 QUIMIOTERAPIA COMBINADA
 MYCOBACTERIUM LEPRAE/metab
 MYCOBACTERIUM LEPRAE/fisiol
 DAPSONA/uso terap
 RIFAMPINA/uso terap
 CLOFAZIMINA/uso terap
 OFLOXACINO/uso terap
 MINOCICLINA/uso terap
 CLARITROMICINA/uso terap
Limits:ESTUDO COMPARATIVO
Location:BR191.1; 09311/s


  2 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:18325
Author:Pares, Y
Title:La lepre: vers une nouvelle approche thérapeuthique pharmacopée et médicine traditionnelles perspective d'avenir ?-
Source:Senegal; s.n; 1980. 12p p. .
Descriptors:HANSENIASE/hist
HANSENIASE/terap
HANSENOSTATICOS/clas
HANSENOSTATICOS/hist
HANSENOSTATICOS/farmacol
DAPSONA/hist
 DAPSONA/uso terap
 Aralia
 ARSÊNICO/uso terap
 ANTIMÔNIO/uso terap
Limits:HUMANO
Location:BR191.1; 00412/s


  3 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:18213
Author:Mathew, D; Kishore, B. Nanda ; Shwethadri, G. K; Sukumar; Shetty, N. J
Title:An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of sixed duration therapy ..-
Source:s.l; s.n; 2004. 8 p. tab.
Abstract:The presente study was carried out involving 25 patients with paucibacillary leprosy who attended the outpatient department of dermatology of Father Muller's Medical College Hospital during the period January 2001 to March 2002. All the patients were examined clinically and histopathologically at the beginning and at the end of six months of MDT and relevant data recorded. Clinicopathological correlation with histopathological classification before MDT was 72% and 68% at the end of MDT in our study. At the end of treatment 4 (16%) cases were clinically active and 8 (32%) were histopathologically active. The study showed that active cases were siginificantly reduced as a result of MDT, both clinically and histopatologically. The histopathological activity that outlasts MDT may be due to the bacillary fragments that persist; but clincial activity coupled with histopathological activity seen in 2 patients at the end of 6 months of MDT was possibly an indicator of relapse and these patients and similar others need to be follewed up for a longer duration. Is this study, resolution of granuloma and clinical activity after completion of MDT were assessed (AU).
Descriptors:HANSENIASE TUBERCULOIDE/compl
HANSENIASE TUBERCULOIDE/patol
HANSENIASE TUBERCULOIDE/fisiopatol
HANSENIASE TUBERCULOIDE/terap
RESULTADO DE TRATAMENTO
HANSENOSTATICOS/admin
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
QUIMIOTERAPIA COMBINADA
HANSENIASE/clas
 HANSENIASE/diag
 HANSENIASE/terap
Limits:HUMANO
Location:BR191.1; 08999/s


  4 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:17456
Author:Shepard, C. C
Title:Experimental chemotherapy in leprosy ?-
Source:s.l; s.n; 1976. 9p p. .
Abstract:The Memorandum reviews the considerable progress that has been made in research on the chemotherapy of leprosy during the last 10-15 years, as a result of which it is now possible to study the same topics in leprosy as are studied in other bacterial diseases. Thus drugs have been screened in mice for their activity against Mycobacteerium leprae. Those that have been found to have the greatest activity against M. leprae at acceptable dosages-dapsone, rifampicin, and clofazimine-have been characterized in terms of the minimal effective dosage and rate of bacterial kill. Similarly, their pharmacokinetics in man and in certain animals have been defined. The theoretical basis for drug trials in leprosy patients is discussed in terms of the number of viable and the number of dead M.leprae that remain of various stages of therapy.
Descriptors:HANSENIASE/clas
HANSENIASE/quimioter
HANSENOSTATICOS/admin
HANSENOSTATICOS/clas
HANSENOSTATICOS/metab
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/farmacocin
QUIMIOTERAPIA COMBINADA
Limits:RELATO DE CASO
Location:BR191.1; 00945/s


  5 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:17210
Author:S, B. B. M. Dharmendra; Chatterjee, K. R.
Title:Thiosemicarbazone in the treatment of leprosy.
Source:Lepr Ind;24(3):93-, july, 1952. tab.
Abstract:(I) The previous work with thiosemicarbazone in the treatment of leprosy is summarised. (2) Siocarbazone brand of thiosemicarbazone has been used in 52 cases of leprosy, 9 untraeded neural cases, 27 untreated lepromatous cases and 16 previously treated lepromatous cases, 15 with sulphones, and I with hydnocarpus oil. The duration of treatment has from 2 months to 16 months with an average of I0 months. (3) The patients have stood the drug well and there has been satisfactory clinical and bacteriological response. In addition to usual therapeutic affects, special features with thiosemicarbazone treatment have been the complete or partial restoration of sensation in the anaesthetic patches and in the limbs with polyneuritic type of anaesthesia, replacement of deseased nails by new ones, and growth of new hair in depilated areas. Considering the short period of treatment those features are rather remarkable. (4) In the toxicity of thiosemicarbazone seems to be less than that of the sulphones specially in relation to its effect on the haemopoietic system. However, the thiosemicarbazone is not as free from toxicity as described by some workers eho have used it in leprosy. A special kind of toxicity which indicates specific intolerance has been noticed and this has been manifested by sudden rise of temperature even after small doses of the drug (AU).
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/admin
HANSENOSTATICOS/ef adv
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/tox
HANSENOSTATICOS/uso terap
Location:BR191.1


  6 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:16613
Author:Emerson, G. A.
Title:Some pharmacologic effects of the choline ester of chaulmoogric acid.
Source:Int. J. Lepr;9(3):341-345, July-Sept. 1941. graf.
Abstract:The choline ester of chaulmoogric acid has a small but definite muscarine-like activity, slightly greater than that of molescularly equivalent amounts of choline. In addition it has direct harmful effects upon tissues. A fraction of the ester may be rapidly hydrolized to form choline chaulmoograte. Chaulmoogrylcholine is unsuited for antileprosy use since its toxicity precludes administration of significant amounts of chaulmoogric acid in this form. (AU).
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/farmacol
CHAULMOOGRA/farmacol
CHAULMOOGRA/uso terap
Limits:ANIMAL
Location:BR191.1


  7 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:16424
Author:Germond, R. C.
Title:Treatment of lepra reaction and lepromatous ulcers by antimony and the arsphenamides.
Source:Int. J. Lepr;8(1):29-39, Jan.-Mar. 1940. graf.
Abstract:1- Intramuscular injection of fouadin in acute lepra reaction causes a fall in temperature with simultaneous clinical improvement in a large proportion of cases, provided they are definitely acute. 2- The same results are obtainable by the injection of prontosil. The action of this drug appears to be more constant and more pronounced than that of fouadin. 3- Intra-arterial injection of 5 to 10 cc. of soluseptasine in septic leprotic ulcers and burns results in their rapid cleansing with corresponding improvement in the general condition. Growth of healthy granulations is promoted and dead tissue is rapidly eliminated. 4- Despite the presumably greater concentration of the drug on the injected side, the effect does not seem to be more pronounced than on the noninjected side. 5- The results obtained by the intramuscular injection of soluseptasine do not seem to be inferior to those obtained by the employment of the intra-arterial route. 6- The hypothesis that acute lepra reaction is due to secondary infection is rendered more plausible by the success of prontosil in the treatment of this condition. 7- Neither fouadin nor the arsphenamides appear to possess the least curative value on leprosy itself. Their virtue lies in their action against the inflammatory element (secondary infection). 8- The treatment of burns and lepromatous ulcers is greatly simplified by chematherapy. Their rapid cleansing is insured without active local treatment, and elastoplast can be applied at a much earlier date than ordinarily. 9- In neural cases chematherapy does not dispense with surgical treatment in the presence of necrosed bone. When, on the other hand, the septic condition originates in the tendon sheaths or small articulations, chemotherapy may render surgical measures unnecessary. 10- Further experimentation to determine the value of chemotherapy in acute laryngeal obstruction and ulcerations of the mouth in advanced lepromatous cases is desirable. 11- Should the results obtained in the present series be confirmed by other authors, the treatment of septic conditions in leper asylums will be revolutionized. (AU).
Descriptors:HANSENIASE/clas
HANSENIASE/compl
HANSENIASE/quimioter
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
Limits:HUMANO
Location:BR191.1


  8 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:16204
Author:Anon.
Title:Analysis of chaulmoogra oils. IV. Hydnocarpus anthelmintica oil. V. Taraktogenos Kurzii (chaulmoogra) oil.
Source:In: Cole, Howard Irving; Cardoso, Humberto T.Analysis of chaulmoogra oils. s.l, s.n, 1941. p.223-228tab.
Abstract:The qualitative and quantitative analyses of Hydnocarpus anthelmintica and Taraktogenos kurzii (chaulmoogra) oils have been made by the methods described in the first article of this series. They are the first quantitative analyses that have been made of these two important medicinal oils. The percentage compositions of these oils are given in Table I. A summary of the characteristics ans percentage compositions of the five oils of the chaulmoogra group so far analyzed in this series of articles is given in Tables IV and V. (AU).
Descriptors:CHAULMOOGRA/hist
HANSENIASE/quimioter
HANSENOSTATICOS/hist
HANSENOSTATICOS/isol
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
Limits:ESTUDO COMPARATIVO
Location:BR191.1


  9 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:16202
Author:Cole, Howard Irving; Cardoso, Humberto T
Title:Analysis of chaulmoogra oils ..-
Source:s.l; s.n; 1941. 14 p. tab.
Abstract:Four optically active fatty acids hitherto unknown have been discovered in Hydnocarpus wightiana oil. They have been named alepric, aleprylic, aleprestic and aleprolic acids. The characteristics of these new acids and their ethyl esters are given and their relationship to their previously known homologs, hydnocarpic and chaulmoogric acids, is shown. (AU).
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/isol
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
CHAULMOOGRA/uso terap
Location:BR191.1


  10 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:15764
Author:Bhattacharya, D. B.
Title:Notes on the treatment of a few cases of leprosy by potassium iodide and iodine.
Source:Lepr Ind;6(3):140-145, july, 1934. tab.
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/isol
HANSENOSTATICOS/uso terap
Location:BR191.1


  11 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:15751
Author:Chatterji, S. N.
Title:A note on thyroid treatment in leprosy.
Source:Lepr Ind;6(2):84-85, apr., 1934. tab.
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/admin
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
Limits:HUMANO
Location:BR191.1


  12 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:15735
Author:Cochrane, R. G.
Title:Treatment of leprosy.
Source:In: Anon.Calcutta Conference Papers. Calcutta, s.n, mar.,27 1933. p.42-46.
Conference:Present in: Calcutta Leprosy Conference, Calcutta, mar 27, 1933.
Descriptors:HANSENOSTATICOS/admin
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
Location:BR191.1


  13 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:15656
Author:Muir, E.
Title:Potassium iodide in the treatmente of leprosy and in confirming its arrest.
Source:Lepr Ind;4(2):76-78, apr. 19132. .
Descriptors:HANSENOSTATICOS/admin
HANSENOSTATICOS/imunol
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
HANSENIASE/compl
Limits:HUMANO
Location:br191.1


  14 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:15450
Author:Ryrie, Gordon A.
Title:The therapeutic effects of phthalic acid salts.
Source:Int. J. Lepr;4(2):201-206, Apr.-Jun. 1936. .
Abstract:The magnesium, calcium, potassium-hydrogen and cotarnine salts of phthalic acid have been tried out, on twenty patients each, over a period of six months by intravenous injections twice a week. Intravenous injections of magnesium, calcium and potassium-hydrogen phthalate appear to have no therapeutic effect in leprosy in doses of 20 cc. of a 1 per cent solution. Out of nineteen cases treated with intravenous injections of cotarnine phthalate, in 20 cc. doses, first of a 1 per cent solution and later a 2 per cent solution, twice a week, twelve showed marked improvement, four slight improvement and three no change. The inprovement in these cases occurred only during the first three months of treatment. The clinical improvement appears to be accompanied by a general increase in resistance as indicated by a drop of over 25 per cent in the sedimentation rate of twelve of the patients. It is suggested that the effect of the phthalate group in leprosy is dependent to some extent on the length of time the drug is retained in the body. (AU).
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/admin
HANSENOSTATICOS/sangue
HANSENOSTATICOS/hist
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
FLUORESCEINAS/admin
 FLUORESCEINAS/uso terap
Limits:HUMANO
Location:BR191.1


  15 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:15399
Author:Souza Araujo, Heraclides Cesar de.
Title:Treatment of leprosy by methylene blue.
Source:Int. J. Lepr;3(4):471-473, Oct.-Dec. 1935. .
Descriptors:HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
HANSENIASE/quimioter
Limits:HUMANO
Location:BR191.1


  16 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:15309
Author:Wade, H. W.
Title:Tuberculoid changes in leprosy. III. The pathology of a nerve abscess.
Source:Int. J. Lepr;2(3):293-300, Aug.-Oct. 1934. ilus.
Abstract:A description is given of the histopathology of a specimen of the peculiar chronic leprous nerve abscess of India, the frequency of wich in that country - if not its occurrence at all - constitutes one of the regional peculiarities of the disease. The tissue is a highly organized tuberculoid granuloma, with outer capsular and inner pseudo-villous layers. The latter consists of isolated, vascular lymphoid follicles clothed top and sides with a layer of proliferating tuberculoid tissue; necrosis of this occuring beyond a given distance produces villosities in a strikingly regular manner. The cpsule is of comparatively finely-knit structure, well supplied with vessels; it apparently derived from the perineurium, indicating that the process arose within a nerve cord. This finding, in view of the evident frequence of tuberculoid affection of the nerve in India, and on the other hand the non occurrence in the Philippines of abscess of this kind and the rarity and unimportance there of tuberculoid lesions of the nerve, indicates that the latter forms the basis of the former. In view of the clinical features, and especially of Lowe´s opinion that this absces formation is a reaction condition and greatly increased in frequency by the use of potassium iodite, it is accepted as entirely probable that the condition is a manifestation of lepra reaction and, more specifically, of chronic, persistent lepra reaction in a tuberculoid lesion. The extensive epithelioid production is in keeping with findings in chronic reaction of tuberculoid skin lesions and is a further indication that that feature is characteristic of chronic reaction in lesions of that nature. Leprosy bacilli were not found in this specimen, though Lowe found a few, apparently degenerated, in about half of his cases. However, though there is need of further control work, the causative agent is in all probability that of leprosy. It is believed that these abscesses are worthy of further attention. It remains to be determined whether they are regularly tuberculoid and regularly associated with reaction. The fact that they are apparently limited to males involves an intriguing question. Finally, material from these lesions might prove of special value in an investigation of the hypothetical submicroscopic form or phase of the leprosy bacillus. (AU).
Descriptors:HANSENIASE TUBERCULOIDE/diag
HANSENOSTATICOS/ef adv
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
GRANULOMA/patol
Limits:HUMANO
Electronic Medium:http://www.ilsl.br
Location:BR191.1


  17 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:15284
Author:Nolasco, J. O.
Title:Histologic studies on the plancha or infiltration method of leprosy treatment.
Source:Int. J. Lepr;2(2):159-174, Apr.-July 1934. ilus.
Abstract:1- Leprotic lesions infiltrated once or a few times with the iodized Hydnocarpus wightiana ethyl esters as made at Culion show, 24 hours after such injection, polymorphonuclear and large mononuclear exudation, with fibrin deposit and degeneration of the exudate cell (Section I). 2- Leprotic lesions similarly injected for many months show, histologically, marked reduction of the lepromatous tissue and fragmentation of the bacilli, as compared with similar control lesions which have been subjected only to the influence of simultaneous intramuscular injections. In these treated lesions are found large mononuclear leucocytes containing peculiar yellowish globules ("globulated cells"), not seen in untreated lesions. (Section I). 3- The particularly rapid effect of the infiltration method of treatment is due evidently to local action, whether this be the reaction to irritation, or the greater concentration of the drug - which may have a specific effect on the bacillus - or both. (Section I). 4- The skin of non-lepers similarly infiltrated with the iodized hydnocarpus ethyl esters, shows 24 hours after an injection an acute reaction similar to that seen in a leproma. (Section II)...(AU).
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/admin
HANSENOSTATICOS/farmacol
HANSENIASE/patol
Location:BR191.1


  18 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:15282
Author:Ryrie, Gordon A.
Title:On the use of fluorescein and phthallic acid in leprosy.
Source:Int. J. Lepr;2(2):139-147, Apr.-July 1934. tab.
Abstract:(1) In the treatment of leprosy cases with intravenous injections of aniline dyes, fluorescein has seemed to us to give the most stable effects. (2) Sixty-four cases have been treated with intravenous injections of fluorescein over a period of four months. (3) After six weeks treatment about 60 per cent of these cases showed greather or less specific response, based on clinical examination of the lesions and laboratory findings. (4) The improvement rate dropped to 43 per cent on continuing the treatment for four months. (5) Nine cases have been treated with resorcin blue (resorcin being one of the components of fluorescein). No effect was obtained. (6) Sixteen patients have been treated for two months with intravenous injections of phthallic acid (the other component of fluorescein) with greater or less lesion response in 62 per cent of cases. (AU).
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/admin
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/hist
HANSENOSTATICOS/uso terap
Limits:ESTUDO COMPARATIVO
Location:BR191.1


  19 / 24 HANSEN  
              first record previous record next record last record
select
to print
Id:15250
Author:Anderson, H. H; Emerson, George; Leake, C. D.
Title:A pharmacological evaluation of certain antileprotic drugs.
Source:Int. J. Lepr;2(1):39-55, Jan.-Mar. 1934. ilus, tab, graf.
Abstract:A pharmacologic method for evaluating antileprotic drugs is presented which includes the following considerations: (a) acute toxicity in normal animals; (b) chronic toxicity in leprous rats; (c) rate of absorption local irritation and excretion in human beings; (d) lethal action on Myco. leprae hominis in vitro; (e) therapeutic effectiveness in a supposed culture of Myco. leprae muris in rats; (f) an arbitrary therapeutic index based on treatment results in infected rats and ratio of toxicity to action in vitro. When we estimative relative effectiveness in this way, the five drugs considered may be ranked as follows, the best agent being placed first: ethyl esters of chaulmoogra oil, alepol, ethyl di-N-heptyl acetate, di-hydrochaulmoogryl p-phenetidine sulphonate, and chaulmoogryl p-phenetidine sulphonate. The mechanism of antileprotic action is discussed. For the compounds studied the most therapeutically efficient are those having optical activity, the greatest degree of unsaturation and the cyclopentenyl group. We were unable to demostrate an increase in lipolytic activity of the tissues of leprous rats with treatment. An important factor in the effectiveness of treatment with chaulmoogric acid derivatives is the amount of chaulmoogric acid that can be given safely. To give a sufficient amount is difficult with water-soluble chaulmoogra derivatives. It is recommended that drugs be subjected to pharmacologic study before clinical use, inasmuch as the relative value in human leprosy of four of the drugs (those which have had clinical trial) could have been predicted if a critical laboratory investigation had been made beforehand. Such a procedure would obviate possible toxic effects in humans and loss of time with ineffective or unsatisfactory agents; further, more complete data on the action of drugs in this disease would be avilable if animal experimentation were resorted to more frequently. (AU).
Descriptors:HANSENIASE/quimioter
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/uso terap
Location:BR191.1


  20 / 24 HANSEN  
              first record previous record
select
to print
Id:15218
Author:Muir, Ernest.
Title:Treatment of leprosy: a review.
Source:Int. J. Lepr;1(4):407-458, Oct. 1933. ilus.
Descriptors:HANSENOSTATICOS/hist
HANSENOSTATICOS/admin
HANSENOSTATICOS/ef adv
HANSENOSTATICOS/isol
HANSENOSTATICOS/farmacol
HANSENOSTATICOS/farmacocin
HANSENOSTATICOS/tox
HANSENOSTATICOS/uso terap
HANSENIASE/quimioter
 HANSENIASE/terap
Limits:HUMANO
Location:BR191.1



page 1 de 2 go to page        
   


Refine the search
  Database : HANSEN Advanced form   
Search for : Free form   

    Search in field  
1  
2
3
 
           



Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO
Latin American and Caribbean Center on Health Sciences Information